The ongoing revolution in genetics is playing an increasingly important role in our understanding of the [Parkinson’s] disease while also revealing why it varies so much from patient to patient. There have been dozens of mutations and variants associated so far with the disease. We are just beginning to understand the role our genes play in the development of neurological diseases but an immense amount of progress has been made in the last 15 years since the human genome was sequenced.
…
A better understanding of genetics will help unlock a cascade of other problems that surround this disease including mitochondrial dysfunction, lysosomal degradation, neuroinflammation, gut bacteria, and epigenetics, among others.
…
Therapies on the Horizon (5 to 10 years)
Immunotherapies – …we may be able to harness the bodies immune system to stop the protein from clumping while also mitigating the bodies natural inflammatory responses that damages neurons.
Pharmacogenetics – … Eventually, instead of making one drug for everybody, we will be able to tailor drugs to better fit each person’s unique condition.
Related on the SLP
Stem Cell Therapies – Though there were a series of trials in the 90’s that had mixed results, recently a number of labs around the world have begun reexamining the therapeutic potential of stem cells. …
Gene Modification Therapies – …The most popular one today is called CRISPR, a technique that already allows researchers to cut and paste genetic code, changing the genome of living organisms…
The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion, and analysis. Read full, original post: We’re About to Enter a New Era in Parkinson’s Disease Treatments
For more background on the Genetic Literacy Project, read GLP on Wikipedia.
